{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:26:44Z","timestamp":1791973604824,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberous-sclerosis-complex (TSC) is associated with a high lifetime risk of severe complications. Clinical manifestations are largely variable and diagnosis is often missed. Sclerotic-bone-lesions (SBL) could represent a potential imaging biomarker for the diagnosis of TSC. In this study, computed tomography (CT) data sets of 49 TSC patients (31 females) were included and compared to an age\/sex matched control group. Imaging features of SBLs included frequency, size and location pattern. Sensitivities, specificities and cutoff values for the diagnosis of TSC were established for the skull, thorax, and abdomen\/pelvis. In TSC patients, 3439 SBLs were detected, including 665 skull SBLs, 1426 thoracal SBLs and 1348 abdominal\/pelvic SBLs. In the matched control-collective, 157 SBLs could be found. The frequency of SBLs enabled a reliable differentiation between TSC patients and the control collective with the following sensitivities and specificities. Skull: \u22655 SBLs, 0.783, 1; thorax: \u22654 SBLs, 0.967, 0.967; abdomen\/pelvis: \u22655 SBLs: 0.938, 0.906. SBL size was significantly larger compared to controls (p\u2009&lt;\u20090.05). Based on the frequency, size and location pattern of SBLs TSC can be suspected. SBLs may serve as a potential imaging biomarker in the workup of TSC patients.<\/jats:p>","DOI":"10.1038\/s41598-018-19399-7","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T12:54:36Z","timestamp":1515675276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sclerotic bone lesions as a potential imaging biomarker for the diagnosis of tuberous sclerosis complex"],"prefix":"10.1038","volume":"8","author":[{"given":"Susanne","family":"Brakemeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-4542","authenticated-orcid":false,"given":"Lisa C.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Zukunft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Diederichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R.","family":"Makowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"2","key":"19399_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","volume":"59","author":"K Budde","year":"2012","unstructured":"Budde, K. & Gaedeke, J. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition. Am J Kidney Dis. 59(2), 276\u201383 (2012).","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"19399_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup, H. & Krueger, D. A. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatric neurology. 49(4), 243\u201354 (2013).","journal-title":"Pediatric neurology."},{"issue":"13","key":"19399_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino, P. B., Nathanson, K. L. & Henske, E. P. The tuberous sclerosis complex. The New England journal of medicine. 355(13), 1345\u201356 (2006).","journal-title":"The New England journal of medicine."},{"issue":"4","key":"19399_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","volume":"48","author":"GL Holmes","year":"2007","unstructured":"Holmes, G. L. & Stafstrom, C. E. Tuberous Sclerosis Study G. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 48(4), 617\u201330 (2007).","journal-title":"Epilepsia."},{"issue":"7","key":"19399_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00467-016-3474-6","volume":"32","author":"S Brakemeier","year":"2017","unstructured":"Brakemeier, S., Bachmann, F. & Budde, K. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. Pediatric Nephrology. 32(7), 1137\u201344 (2017).","journal-title":"Pediatric Nephrology."},{"issue":"1","key":"19399_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/58.1.1","volume":"58","author":"JF Holt","year":"1952","unstructured":"Holt, J. F. & Dickerson, W. W. The osseous lesions of tuberous sclerosis. Radiology. 58(1), 1\u20138 (1952).","journal-title":"Radiology."},{"issue":"4","key":"19399_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1148\/89.4.701","volume":"89","author":"NN Komar","year":"1967","unstructured":"Komar, N. N., Gabrielsen, T. O. & Holt, J. F. Roentgenographic appearance of lumbosacral spine and pelvis in tuberous sclerosis. Radiology. 89(4), 701\u20135 (1967).","journal-title":"Radiology."},{"issue":"7","key":"19399_CR8","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1148\/rg.e32","volume":"28","author":"S Umeoka","year":"2008","unstructured":"Umeoka, S. et al. Pictorial review of tuberous sclerosis in various organs. Radiographics: a review publication of the Radiological Society of North America, Inc. 28(7), e32 (2008).","journal-title":"Radiographics: a review publication of the Radiological Society of North America, Inc."},{"issue":"8","key":"19399_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd, C. W., Gomez, M. R., Lie, J. T. & Crowson, C. S. Causes of death in patients with tuberous sclerosis. Mayo Clinic proceedings. 66(8), 792\u20136 (1991).","journal-title":"Mayo Clinic proceedings."},{"issue":"4","key":"19399_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","volume":"66","author":"MJ Eijkemans","year":"2015","unstructured":"Eijkemans, M. J. et al. Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. Am J Kidney Dis. 66(4), 638\u201345 (2015).","journal-title":"Am J Kidney Dis."},{"key":"19399_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.urology.2016.04.027","volume":"95","author":"J Bissler","year":"2016","unstructured":"Bissler, J. et al. Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. Urology. 95, 80\u20137 (2016).","journal-title":"Urology."},{"key":"19399_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0185-y","volume":"16","author":"C Cabrera-Lopez","year":"2015","unstructured":"Cabrera-Lopez, C. et al. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated. BMC medical genetics. 16, 39 (2015).","journal-title":"BMC medical genetics."},{"issue":"2","key":"19399_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1378\/chest.12-2813","volume":"144","author":"CJ Cudzilo","year":"2013","unstructured":"Cudzilo, C. J. et al. Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest. 144(2), 578\u201385 (2013).","journal-title":"Chest."},{"issue":"5","key":"19399_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","volume":"73","author":"N Nathan","year":"2015","unstructured":"Nathan, N. et al. Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus. Journal of the American Academy of Dermatology. 73(5), 802\u20138 (2015).","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"6","key":"19399_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24523","volume":"78","author":"DN Franz","year":"2015","unstructured":"Franz, D. N. et al. Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann Neurol. 78(6), 929\u201338 (2015).","journal-title":"Ann Neurol."},{"issue":"5","key":"19399_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-0030-1269906","volume":"41","author":"DN Franz","year":"2010","unstructured":"Franz, D. N., Bissler, J. J. & McCormack, F. X. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 41(5), 199\u2013208 (2010).","journal-title":"Neuropediatrics."},{"key":"19399_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","volume":"60","author":"M Sahin","year":"2016","unstructured":"Sahin, M. et al. Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference. Pediatric neurology. 60, 1\u201312 (2016).","journal-title":"Pediatric neurology."},{"issue":"3","key":"19399_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1148\/radiol.09090227","volume":"254","author":"NA Avila","year":"2010","unstructured":"Avila, N. A. et al. CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis. Radiology. 254(3), 851\u20137 (2010).","journal-title":"Radiology."},{"issue":"2","key":"19399_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","volume":"57","author":"RA Schwartz","year":"2007","unstructured":"Schwartz, R. A., Fernandez, G., Kotulska, K. & Jozwiak, S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. Journal of the American Academy of Dermatology. 57(2), 189\u2013202 (2007).","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"5","key":"19399_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archneurpsyc.1955.02330110041004","volume":"73","author":"WW Dickerson","year":"1955","unstructured":"Dickerson, W. W. Nature of certain osseous lesions in tuberous sclerosis. AMA archives of neurology and psychiatry. 73(5), 525\u20139 (1955).","journal-title":"AMA archives of neurology and psychiatry."},{"issue":"12","key":"19399_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/088307389801301206","volume":"13","author":"ES Roach","year":"1998","unstructured":"Roach, E. S., Gomez, M. R. & Northrup, H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. Journal of child neurology. 13(12), 624\u20138 (1998).","journal-title":"Journal of child neurology."},{"issue":"7","key":"19399_CR22","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1148\/rg.317115093","volume":"31","author":"LL Ihde","year":"2011","unstructured":"Ihde, L. L. et al. Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics: a review publication of the Radiological Society of North America, Inc. 31(7), 1865\u201382 (2011).","journal-title":"Radiographics: a review publication of the Radiological Society of North America, Inc."},{"key":"19399_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(05)70467-0","volume":"350","author":"T Grieser","year":"1997","unstructured":"Grieser, T. & Minne, H. W. Systemic mastocytosis and skeletal lesions. Lancet 350, 1103\u20134 (1997).","journal-title":"Lancet"},{"issue":"5","key":"19399_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11940-013-0249-2","volume":"15","author":"DA Krueger","year":"2013","unstructured":"Krueger, D. A. Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex. Curr Treat Options Neurol. 15(5), 618\u201333 (2013).","journal-title":"Curr Treat Options Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19399-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19399-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:05:35Z","timestamp":1671584735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19399-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19399"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19399-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B. has received honoraria and travel grants from Bristol-Myers Squibb, Novartis, Roche, Pfizer, and Alexion Astellas; K.B. has received research funds and\/or honoraria from Alexion, Astellas, Bristol-Myers Squibb, Chiesi, Fresenius, Genentech, Hexal, Novartis, Otsuka, Pfizer, Roche, Siemens, and Veloxis Pharma; K.U.E., L.V., L.A., G.D., B.H. and M.R.M. declare no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; all authors declare no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"953"}}